Filter Results:
(4)
Show Results For
- All HBS Web
(187)
- Faculty Publications (4)
Show Results For
- All HBS Web
(187)
- Faculty Publications (4)
Page 1 of 4
Results
- Aug 2020
- Conference Presentation
Impacting Grand Challenges: A 'Both/And' Approach
By: Natalie Slawinski, Wendy K. Smith, Robin J. Ely, Tobias Hahn, Andrew J. Hoffman and Anita M. McGahan
In this panel symposium, we seek to build on growing efforts by management scholars to engage with grand challenges and the United Nations’ Sustainable Development Goals (SDGs). Reflective of the All- Academy Theme description, we note that research and scholarship... View Details
Slawinski, Natalie, Wendy K. Smith, Robin J. Ely, Tobias Hahn, Andrew J. Hoffman, and Anita M. McGahan. "Impacting Grand Challenges: A 'Both/And' Approach." Paper presented at the Academy of Management Annual Meeting, Virtual, August 2020.
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- September 2006 (Revised May 2007)
- Case
GE's Jeff Immelt: The Voyage from MBA to CEO
By: Christopher A. Bartlett and Andrew N. McLean
GE believes its ability to develop management talent is a core competency that represents a source of sustainable competitive advantage. Traces the development of a 25-year-old MBA named Jeff Immelt, who 18 years later is named as CEO of GE, arguably the biggest and... View Details
Keywords: Talent and Talent Management; Human Resources; Leadership Development; Leading Change; Business or Company Management; Energy Industry; Technology Industry
Bartlett, Christopher A., and Andrew N. McLean. "GE's Jeff Immelt: The Voyage from MBA to CEO." Harvard Business School Case 307-056, September 2006. (Revised May 2007.)
- October 2003 (Revised November 2006)
- Case
GE's Talent Machine: The Making of a CEO
By: Christopher A. Bartlett and Andrew N. McLean
GE believes its ability to develop management talent is a core competency that represents a source of sustainable competitive advantage. This case traces the development of GE's rich system of human resource policies and practices under five CEOs in the post-war era,... View Details
Keywords: Decision Choices and Conditions; Capital; Selection and Staffing; Leadership Development; Management Succession; Corporate Strategy
Bartlett, Christopher A., and Andrew N. McLean. "GE's Talent Machine: The Making of a CEO." Harvard Business School Case 304-049, October 2003. (Revised November 2006.)